A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas.

Yazmín Odia, Teri N. Kreisl, Dawit Aregawi, Ellen K. Innis, Howard A. Fine

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalJournal of neuro-oncology
Volume125
DOIs
StatePublished - Jan 10 2015

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Pathology

Cite this